People are asking questions and seeking answers to address the burden of kidney cancer worldwide AMSTERDAM-Tuesday, June 20th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk factors such as aging, obesity, high blood pressure and smoking. The lack of answers is why the International Kidney Cancer Coalition (IKCC) and kidney cancer organisations worldwide are marking the first-ever World Kidney Cancer Q&A Day. On June 22, patients, carers, health care professionals and local organisations will be asking questions and seeking answers: What explains the varying incidence of kidney cancer worldwide? High rates incidence are seen in northern and eastern Europe, North America and Australia, with the highest rates estimated in the Czech Republic? How can we address the growing gap in mortality rates for kid ... Read more »

GENEVA -Tuesday, June 20th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherlands, compared original and Next Generation versions of Masimo Patient State Index (PSi, a processed EEG parameter related to the effect of anesthetic agents) during Masimo SedLine® brain function monitoring of patients under propofol and sevoflurane anesthesia.1 SedLine brain function monitoring features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, four EEG waveforms, a Density Spectral Array (DSA, an easy-to-interpret, high-resolution display of bi-hemispheric activity and EEG power), and PSi. Next Generation SedLine enhances PSi to make it less susceptible to electromyographic (EMG) interference and to improve its performance in low-power EEG cases. In the study, Dr. Kuizenga and ... Read more »

PARIS & DARMSTADT, Allemagne-Mercredi 21 Juin 2017 [ ME NewsWire ] (BUSINESS WIRE)--Le Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium est fier d’annoncer que Merck, dont les activités biopharmaceutiques sont exercées sous la dénomination EMD Serono aux États-Unis et au Canada, devient membre de WIN. Le consortium WIN est un réseau de 40 institutions académiques et d’acteurs industriels du monde entier, spécialisé dans des essais cliniques thérapeutiques de nouvelle génération basés sur des biomarqueurs et des programmes innovants de découverte de biomarqueurs, réalisés à l’échelle mondiale, dans le but d’améliorer significativement la survie des patients atteints de cancer. Merck vient donc rejoindre les rangs des acteurs pharmaceutiques du consortium WIN. La stratégie de recherche collaborative mondiale de WIN sera présentée à l’occasion du symposium WIN2017 à Paris, les 26 et 27 juin prochains. Avec le profond engagement de Merck en matière de dévelop ... Read more »

Fiorano Platform seamlessly integrates EBank’s Temenos core banking system with 3rd party suppliers and channels LONDON -Tuesday, June 20th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Fiorano Software, a leader in enterprise integration, today announced that EBank, a major Namibian commercial bank, has successfully implemented Fiorano ESB to integrate its Temenos T24 core banking system. EBank was looking for easy to configure middleware to handle multiple interfaces with the least requirement for onsite programmers. Fiorano ESB‘s out-of-the-box integration capabilities enabled EBank to rapidly onboard partners across multiple delivery channels. “We at EBank are impressed with the flexibility of the Fiorano ESB, Enterprise Service Bus,” says EBank CFO, Gerald Riedel, “The application is user-friendly, highly agile and enables EBank to quickly and securely set up connections with third party systems. Fiorano ESB consumes a fraction of the resources normally required by similar applications ... Read more »